Pulmonary Hypertension (PH) is a relatively rare condition characterized by high blood pressure in the arteries of the lungs. While exact prevalence rates vary, it is estimated that PH affects approximately 15 to 50 individuals per million worldwide. This means that PH is considered a low prevalence disease. It can occur in people of all ages, races, and ethnic backgrounds, and can be caused by various underlying conditions. Early diagnosis and appropriate treatment are crucial in managing this serious condition.
Pulmonary Hypertension (PH) is a relatively rare but serious medical condition characterized by high blood pressure in the arteries of the lungs. It affects the pulmonary arteries, which carry blood from the heart to the lungs to be oxygenated. PH can lead to various complications and significantly impact a person's quality of life.
Estimating the exact prevalence of PH can be challenging due to variations in data collection and diagnostic criteria. However, studies suggest that the prevalence of PH ranges from 10 to 52 cases per million individuals worldwide. It is more commonly observed in certain populations, such as individuals with underlying heart or lung diseases, connective tissue disorders, or genetic predispositions.
Although PH is considered a rare condition, it is important to note that it can be life-threatening if left untreated. Early diagnosis and appropriate management are crucial in improving outcomes for individuals with PH. Symptoms may include shortness of breath, fatigue, chest pain, dizziness, and swelling in the ankles, legs, or abdomen. If you suspect you or someone you know may have PH, it is essential to seek medical attention promptly.